Publications

Sort by: Date | Author | Title

Madsen, C., Pedersen, M. B., Segel, E., Bendix, K., Jensen, B. A., Jensen, P., Moelller, M. B., Johansen, P., Munksgaard, L., Brown, P. & D'Amore, F. A. (2013). upfront autologous stem-cell transplantation in transformed indolent non-hodgkins lymphoma: An outcome analysis. Hematological Oncology, 31.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M., D'Amore, F. A., Pittaluga, S., Jaffe, E. & Wilson, W. H. (2012). Alemtuzumab (ALZ) in combination with Dose-Adjusted EPOC (DA-EPOCH) has higher efficacy in nodal than in extranodal or leukemic peripheral T-cell lymphoma. International Journal of Clinical Oncology.
Gang, AO., Pedersen, M., D'Amore, F. A., Møller-Pedersen, L., Pedersen, BA., Jensen, P., Pedersen, BB., Møller, MB., Gadeberg, O. V., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, TW. & Brown, P. D. N. (2012). A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Blood, 120(21).
Pedersen, M., D'Amore, F. A., Pedersen, L. M., Jensen, B. A., Jensen, P., Pedersen, B. B., Møller, M. B., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S., Klausen, T. W. & Brown, P. D. N. (2012). A new simplified prognostic index with age cut-off of 70 years for patients with diffuse large B-cell lymphoma. A population-based analysis from the Danish Lymphoma Registry, LYFO. Abstract from 54th ASH Annual Meeting and Exposition, Atlanta, United States.
Grant, C., Dunleavy, K., Janik, J. E., Shovlin, M., Steinberg, S. M., D'Amore, F. A., Maryalice, S. S., Pittaluga, S., Jaffe, E. S. & Wilson, W. H. (2012). Efficacy of alemtuzumab (ALZ) in combination with dose-ajusted EPOCH (DA-EPOCH) in untreated nodal peripheral T-cell lymphoma. Journal of Clinical Oncology, 30(15).
D'Amore, F. A., Leppä, S., Gomes da Silva, M., Relander, T., Brown, P. D. N., Weidmann, E., Lauritzsen, GF., Pezzutto, A., Van Hoof, A., Van Gelder, M., Doorduijn, J., Wu, KL., Kluin-Nelemans, JC., Lugtenburg, PJ., Jankovska, M., Merup, M., Fagerli, U.-M., Walewski, J., Hagberg, H. ... Toldbod, H. (2012). First Interim Efficacy and Safety Analysis of an International Phase III Randomized Trial in Newly Diagnosed Systemic Peripheral T-Cell Lymphoma PatientsTreated with Chemotherapy with or without Alemtuzumab and Consolidated by High Dose Therapy. Blood, 120(57).
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkiaer, E., Vornanen, M. & Toldbod, H. (2012). High-dose chemotherapy and autologous stem cell transplantation in previously untreated peripheral T-cell lymphoma - final analysis of a large prospective multicenter study (NLG-T-01). Blood, 118, 331.
Pedersen, M. B. & D'Amore, F. A. (2012). Peripheral T-cell Lymphomas. In Lymphomas -Essentials for Clinicians - ESMO (pp. 61-66)
Gang, AO., Stroem, C., Pedersen, M., D'Amore, F. A., Pedersen, LM., Bukh, A., Pedersen, BB., Moeller, MB., Mortensen, L. S., Gadeberg, O., Ingeberg, S., Mourits-Andersen, T., Pulczynski, S. & Brown, P. D. N. (2012). R-CHOEP-14 improves overall survival in young high-risk patients with diffuse large B-cell lymphoma compared with R-CHOP-14. A population-based investigation from the Danish Lymphoma Group. Annals of Oncology, 23(1), 147-153. https://doi.org/10.1093/annonc/mdr058
D'Amore, F. A., Relander, T., Lauritzsen, GF., Jantunen, E., Hagberg, H., Anderson, H., Holte, H., Ôsterborg, A., Merup, M., Brown, P. D. N., Kuittinen, O., Erlanson, M., Østenstad, B., Fagerli, U.-M., Gadeberg, OV., Sundström, C., Delabie, J., Ralfkiær, E. M., Vornanen, M. & Toldbod, H. (2012). Upfront Autologuos Stem Cell Transplantation in Peripheral T-cell Lymphoma (NLG-T-01). Journal of Clinical Oncology, 30(25), 3093-3099.
D'Amore, F. A., Gomes da Silva, M., Leppa, S., Relander, T., Pezzutto, A., Lauritzsen, GF., Weidmann, E., Van Gelder, M., Merup, M., Hagberg, H., Fagerli, UM., Brown, P. D. N., Boye Hansen, P., Mariz, JM., Jankovska, M., Walewski, J., Doorduijn, J., van Hoof, A., Christiansen, I. ... Toldbod, H. (2011). First interim safety analysis of a phase III randomized trial in a newly diagnosed systemic peripheral T-cell lymphoma trated with CHOP chemotherapy with or without alemtuzumab and consolidated by autologous hematopoietic stem cell transplant. Blood, 118, 4110.
Jantunen, E., Relander, T., Lauritzsen, G., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Østenstad, B., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M. & D'Amore, F. A. (2011). Intensive induction chemotherapy followed by autologous stem cell transplantation (ASCT) in patients with enteropathy-associated T-cell lymphoma: a prospective study by the Nordic Lymphoma Group (NLG-T-01). Blood, 116(21), 3565.
Hohloch, K., Lorsbach, M., Windemuth-Kieselbach, C., Gomez-Codina, J., Likesch, W., Jurczak, W., Cacchione, R., Suh, C., Johnsen, AR., D'Amore, F. A., Decaudin, D., Zinzani, PL. & Trümper, L. (2011). Radioimmunotherapy confers long-term survival to lymphoma patients with acceptable toxicity: Registry analysis of 1100 patients by the international Radioimmunotherapy network (RIT-N). Journal of Nuclear Medicine, 52(9), 1354-1360.
Clausen, M., Segel, E., Brandsborg, M. & D'Amore, F. A. (2011). Rituximab-induced long term remission in heavily pretreated, chronic idiopathic thrombochytopenic purpura. European Journal of Haematology, 86(3), 256-59.
Agostinelli, C., Gallamini, A., Rigacci, L., Vitolo, U., Stracqualursi, L., Piccaluga, P., Stelitano, C., Patti, C., Argani, L., Broccoli, A., Levis, A., D'Amore, F. A., Zinzani, P. & Pileri, SA. (2011). The prognostic value of biologic markers in classical Hodgkin Lymphoma (CHL) patients. Annals of Oncology, 22(4), 206.
Relander, T., Lauritzsen, G. F., Jantunen, E., Hagberg, H., Anderson, H., Cavallin-Ståhl, E., Holte, H., Østerborg, A., Merup, M., Brown, P. D. N., Østenstad, B., Kuittinen, O., Erlanson, M., Fagerli, UM., Gadeberg, O., Sundström, C., Delabie, J., Ralfkier, E., Vornanen, M. & D'Amore, F. A. (2010). favorable outcome in ALK-negative anaplastic large-cell lymphoma following intensive induction chemotherapy and autologous stem cell transplantation (ASCT): a prospective study by the Nordic Lymphoma Group (NLG-T-01). Blood, 116(21).
d'Amore, F., Radford, J., Relander, T., Jerkeman, M., Tilly, H., Osterborg, A., Morschhauser, F., Gramatzki, M., Dreyling, M., Bang, B. & Hagberg, H. (2010). Phase II trial of zanolimumab (HuMax-CD4) in relapsed or refractory non-cutaneous peripheral T cell lymphoma. British Journal of Haematology, Supplement, 150(5), 565-73. https://doi.org/10.1111/j.1365-2141.2010.08298.x
Segel, E., Sørensen, B., D'Amore, F. A. & Hokland, P. (2010). Successful peripheral blood stem cell harvest in mobilization-refractory lymphoma patients. Bone Marrow Transplantation, 45(suppl. 2), 258.
Jepsen, J. R., d'Amore, F., Baandrup, U., Clausen, M. R., Gottschalck, E. & Aasted, B. (2009). Aleutian mink disease virus and humans. Emerging Infectious Diseases (Print Edition), 15(12), 2040-2. https://doi.org/10.3201/eid1512.090514
D'Amore, F. A., Jurczak, W., Skotnicki, A. B., Deptala, A., Windemuth-Kieselbach, C., Lorsbach, M., Delaloye, A. B., Cheolwon, S., Zinzani, P. L., Cacchione, R., Linkesch, W. & Truemper, L. H. (2009). Consolidation with radioimmunotherapy may prolong survival in first remission of mantle cell lymphoma patients uneligible for stem cell transplantation, an analysis of the international RIT-network. Blood, 114(22), 22.
d'Amore, F. A., Jantunen, E. & Relander, T. (2009). Hemopoietic Stem Cell Transplantation in T-cell Malignancies:Who, When and How? Current Hematologic Malignancy Reports, 4, 236-244.
Zinzani, P. L., d'Amore, F., Bombardieri, E., Brammer, C., Codina, J. G., Illidge, T., Jurczak, W., Linkesch, W., Morschhauser, F., Vandenberghe, E. & Van Hoof, A. (2008). Consensus conference: implementing treatment recommendations on yttrium-90 immunotherapy in clinical practice - report of a European workshop. European Journal of Cancer, 44(3), 366-73. https://doi.org/10.1016/j.ejca.2007.12.008